Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome

• Published in: Blood 2009-09, Vol.114 (13), p.2753-2763
• Main Authors: Cabelof, Diane C., Patel, Hiral V., Chen, Qing, van Remmen, Holly, Matherly, Larry H., Ge, Yubin, Taub, Jeffrey W.
• Format: Article
• Language: English
• Subjects: Base Sequence; Biological and medical sciences; Cell Transformation, Neoplastic - genetics; Child; Chromosome aberrations; Cystathionine beta-Synthase - genetics; Cystathionine beta-Synthase - metabolism; DNA Mutational Analysis; Down Syndrome - complications; Down Syndrome - genetics; Female; Fetus - metabolism; GATA1 Transcription Factor - genetics; GATA1 Transcription Factor - metabolism; Gene Deletion; Gene Duplication; Genetic Predisposition to Disease; Hematologic and hematopoietic diseases; Humans; Leukemia, Megakaryoblastic, Acute - etiology; Leukemia, Megakaryoblastic, Acute - genetics; Male; Medical genetics; Medical sciences; Molecular Sequence Data; Mutagenesis - physiology; Mutagenesis, Insertional - physiology; Myeloid Neoplasia
• ISSN: 0006-4971; 1528-0020
• DOI: 10.1182/blood-2008-11-190330

Down syndrome (DS) children have a unique genetic susceptibility to develop leukemia, in particular, acute megakaryocytic leukemia (AMkL) associated with somatic GATA1 mutations. The study of this genetic susceptibility with the use of DS as a model of leukemogenesis has broad applicability to the understanding of leukemia in children overall. On the basis of the role of GATA1 mutations in DS AMkL, we analyzed the mutational spectrum of GATA1 mutations to begin elucidating possible mechanisms by which these sequence alterations arise. Mutational analysis revealed a predominance of small insertion/deletion, duplication, and base substitution mutations, including G:C>T:A, G:C>A:T, and A:T>G:C. This mutational spectrum points to potential oxidative stress and aberrant folate metabolism secondary to genes on chromosome 21 (eg, cystathionine-β-synthase, superoxide dismutase) as potential causes of GATA1 mutations. Furthermore, DNA repair capacity evaluated in DS and non-DS patient samples provided evidence that the base excision repair pathway is compromised in DS tissues, suggesting that inability to repair DNA damage also may play a critical role in the unique susceptibility of DS children to develop leukemia. A model of leukemogenesis in DS is proposed in which mutagenesis is driven by cystathionine-β-synthase overexpression and altered folate homeostasis that becomes fixed as the ability to repair DNA damage is compromised.